Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website

Pacific Biosciences Of California

Pacific Biosciences Of California reported $692.12M in Equity Capital and Reserves for its fiscal quarter ending in March of 2023.

Equity Capital And Reserves Change
Accelerate Diagnostics AXDX:US USD -38725000 16.46M
Agilent A:US USD 5.78B 172M
Bruker BRKR:US USD 1.2B 85M
Danaher DHR:US USD 51.48B 1.4B
General Electric GE:US USD 31.65B 4.71B
Illumina ILMN:US USD 6.69B 94M
Myriad Genetics MYGN:US USD 835.2M 50.6M
NanoString Technologies NSTG:US USD 13.62M 32.19M
Pacific Biosciences Of California PACB:US USD 692.12M 129.21M
Quidel QDEL:US USD 5B 61.9M
Roche Holding ROG:VX CHF 27.99B 2.8B
Thermo Fisher Scientific TMO:US USD 42.31B 1.72B
Waters WAT:US USD 599.82M 95.34M